Insiders / Koppel Adam
Koppel Adam
CIK 1578965personinsider
Companies
10
First seen
Jan 2, 2015
Last activity
Apr 20, 2026
Companies
All securities held
8 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Kailera Therapeutics, Inc. | Common stock | 22,583,268 |
| Solid Biosciences Inc. | Common stock | 4,034,582 |
Awards
| Company | Security | Shares |
|---|---|---|
| Biogen Inc. | Restricted units | 2,700 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Aptinyx Inc. | Options | 40,000 |
| Foghorn Therapeutics Inc. | Options | 16,000 |
| Kailera Therapeutics, Inc. | Options | 38,300 |
| Ptc Therapeutics, Inc. | Options | 12,000 |
| Solid Biosciences Inc. | Options | 9,650 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Oct 16, 2023 | Buy Open-market buy | CERE Cerevel Therapeutics Holdings, Inc. Common Stock | $125.00M | +5.5M +9.10% | 65,679,781 | high |
| Dec 28, 2021 | Other Shares tendered | DRNA Dicerna Pharmaceuticals Inc Common Stock | $117.82M | -3.1M -100.00% | 0 | low |
| Apr 20, 2026 | Buy Open-market buy | KLRA Kailera Therapeutics, Inc. Common Stock | $25.00M |